MAINTENANCE EN COURS / SITE UNDER MAINTENANCE

Une opération de maintenance est en cours: les résultats de recherches et les exportations peuvent être incohérent.
Site under maintenance: search & exportation results could be inconsistent.
 

Human milk oligosaccharide 2'-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and faecal proteome profiles in mice.

Paone, Paola;Latousakis, Dimitris;Terrasi, Romano;Vertommen, Didier;Cani, Patrice;et.al.
(2024) Gut — Vol. X, n° 1, p. 18 (2024)

Files

PaoneetalGUT2FL2024.pdf
  • Open Access
  • Adobe PDF
  • 12.48 MB
  • https://creativecommons.org/licenses/by/4.0/
Download

Details

Authors
Show more
Abstract
OBJECTIVE: To decipher the mechanisms by which the major human milk oligosaccharide (HMO), 2'-fucosyllactose (2'FL), can affect body weight and fat mass gain on high-fat diet (HFD) feeding in mice. We wanted to elucidate whether 2'FL metabolic effects are linked with changes in intestinal mucus production and secretion, mucin glycosylation and degradation, as well as with the modulation of the gut microbiota, faecal proteome and endocannabinoid (eCB) system. RESULTS: 2'FL supplementation reduced HFD-induced obesity and glucose intolerance. These effects were accompanied by several changes in the intestinal mucus layer, including mucus production and composition, and gene expression of secreted and transmembrane mucins, glycosyltransferases and genes involved in mucus secretion. In addition, 2'FL increased bacterial glycosyl hydrolases involved in mucin glycan degradation. These changes were linked to a significant increase and predominance of bacterial genera Akkermansia and Bacteroides, different faecal proteome profile (with an upregulation of proteins involved in carbon, amino acids and fat metabolism and a downregulation of proteins involved in protein digestion and absorption) and, finally, to changes in the eCB system. We also investigated faecal proteomes from lean and obese humans and found similar changes observed comparing lean and obese mice. CONCLUSION: Our results show that the HMO 2'FL influences host metabolism by modulating the mucus layer, gut microbiota and eCB system and propose the mucus layer as a new potential target for the prevention of obesity and related disorders.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Paone, P., Latousakis, D., Terrasi, R., Vertommen, D., Jian, C., Borlandelli, V., Suriano, F., Johansson, M. E. V., Puel, A., Bouzin, C., Delzenne, N., Salonen, A., Juge, N., Florea, B. I., Muccioli, G., Overkleeft, H., Van Hul, M., & Cani, P. (2024). Human milk oligosaccharide 2′-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and faecal proteome profiles in mice. Gut, X(1), 18. https://doi.org/10.1136/gutjnl-2023-330301 (Original work published 2024)